insights_auto
Outlook: 20.8% bullish·33.3% bearish
Go to analysischevron_right
BSX:NYSE
Boston Scientific Corp
$43.11
arrow_upward
+0.87%(+0.37) 1D
$42.90
arrow_upward
+0.40% (+0.17)todayPre-market
Closed: Oct 9, 4:00:08āÆPM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BSX...
Open
$43.12
High
$43.19
Low
$43.02
Mkt. cap
62.48B
Avg. vol.
19.66M
Volume
18.77K
P/E ratio
17.48
52-wk high
$105.65
52-wk low
$41.38
EPS
$2.47
Beta
0.58
Shares outstanding
1.45B
No. of employees
59K
Open
$43.12
High
$43.19
Low
$43.02
Mkt. cap
62.48B
Avg. vol.
19.66M
Volume
18.77K
P/E ratio
17.48
52-wk high
$105.65
52-wk low
$41.38
EPS
$2.47
Beta
0.58
Shares outstanding
1.45B
No. of employees
59K
News stories
From web sources and news partners
Simply Wall Street
·
2 hours ago
3 Stocks Estimated To Be Trading At Discounts Ranging From 25.7% To 46.4%
ad-hoc-news.de
·
3 hours ago
Boston Scientific names Fitzgerald COO and Boston Scientific stock costs EUR 38.34
Profile
Boston Scientific Corporation is an American biotechnology and biomedical engineering firm and multinational manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.
The company is known for developing the Taxus Stent, a drug-eluting stent that is used to open clogged arteries.
BSC is headquartered in Marlborough, Massachusetts and incorporated in Delaware. Wikipedia
About Boston Scientific Corp
CEOMichael F. Mahoney
Employees59K
FoundedJun 29, 1979
HeadquartersMarlborough, Massachusetts, United States
SectorMedical device
Websitebostonscientific.com